Related Experiment Video
Updated: May 10, 2026

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
Published on: February 20, 2019
Lineage of bone marrow-derived cells in atherosclerosis
Hiroshi Iwata1, Ichiro Manabe, Ryozo Nagai
1Center for Interdisciplinary Cardiovascular Sciences, Harvard Medical School, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA. hiroiwata-circ@umin.ac.jp
Insights
Bone marrow-derived cells, including myeloid and vascular progenitor cells, play complex roles in atherosclerosis, a chronic inflammatory disease. Understanding these roles may reveal new therapeutic targets for atherosclerosis treatment.
Area of Science:
- Cardiovascular Biology
- Immunology
- Cell Biology
Background:
- Atherosclerosis is a chronic inflammatory disease influenced by lipids and atherogenic factors.
- Bone marrow-derived cells, including immune cells and vascular progenitor cells, are increasingly recognized for their roles in atherogenesis.
- The precise functions and lineage identities of these cells in atherosclerosis remain areas of active investigation.
Purpose of the Study:
- To review the current understanding of bone marrow-derived cell contributions to atherosclerosis.
- To highlight the specific roles of myeloid cells and vascular progenitor cells in the disease process.
- To identify knowledge gaps regarding cellular identity and function in atherosclerosis.
Main Methods:
- Literature review of recent studies on bone marrow-derived cells in atherosclerosis.
- Synthesis of information on immune cell subsets and vascular progenitor cells.
- Analysis of current uncertainties in cellular lineage and function.
Main Results:
- Bone marrow-derived cells exhibit diverse and dynamic roles in the pathological process of atherosclerosis.
- Myeloid cells and vascular progenitor cells are key contributors to atherosclerosis development and progression.
- Significant uncertainties persist regarding the specific identities and functions of various bone marrow-derived cell subsets.
Conclusions:
- A comprehensive understanding of bone marrow-derived cell subsets is crucial for advancing atherosclerosis research.
- Further investigation into the pathological roles of these cells may uncover novel therapeutic targets.
- Targeting specific bone marrow-derived cell pathways holds promise for future atherosclerosis treatment strategies.
Abstract:
Atherosclerosis is a chronic inflammatory disease driven by lipids and other atherogenic factors. It is characterized by a dynamic and complex pathological process of bone marrow-derived cells playing divergent roles. Recent studies have begun unraveling the contribution of growing varieties of subsets of immune cells and other bone marrow-derived cells to atherogenesis. For example, bone marrow-derived vascular progenitor cells have been shown to play an important role in the pathogenesis of atherosclerosis. This review provides an overview of the current understanding of contributions of bone marrow-derived cells to atherosclerosis. Particular focus is placed on myeloid cells and vascular progenitor cells. We also summarize the uncertainty surrounding cellular lineage identity and functions. Expansion of our understanding of pathological roles of various subsets of bone marrow-derived cells in atherosclerosis may lead to identification of novel cellular and molecular targets for development of therapeutic strategies.
Related Concept Videos
Atherosclerosis I: Introduction
Inflammation
Coronary Artery Disease II: Pathophysiology
Lineage Commitment
Production of Formed Elements
Most HSCs commit to...
Peripheral Artery Disease I: Introduction

